Rapid start to DBAG Fund VII’s investment period

Deutsche Beteiligungs 21 April 2017 Review
Download PDF

Deutsche Beteiligungs

Rapid start to DBAG Fund VII’s investment period

Investment companies

21 April 2017

Price

€34.13

Market cap

€513m

NAV*

€383m

NAV per share*

€25.46

Premium to NAV

34.1%

*As at 31 December 2016.

Yield

3.5%

Ordinary shares in issue

15.0m

Code

DBAN

Primary exchange

Frankfurt

Sector

Private equity

Benchmark

N/A

Share price/premium performance

Three-year performance vs index

52-week high/low

€36.53

€24.98

€25.46

€23.09

Gearing

Gross*

0.0%

Net cash*

15.5%

*As at 31 December 2016.

Analysts

Gavin Wood

+44 (0)20 3681 2503

Sarah Godfrey

+44 (0)20 3681 2519

Deutsche Beteiligungs is a research client of Edison Investment Research Limited

Deutsche Beteiligungs (DBAG) has continued into FY17 the strong pace of portfolio activity achieved in the previous two financial years, with c €63m of transactions in the year to date, representing the second highest annual level of new investment in more than 10 years. Following DBAG Fund VI’s investment period closing in January 2017, DBAG Fund VII has made a rapid start, with its first two transactions agreed in March and April 2017. The recent strength of transaction activity means that DBAG’s portfolio is relatively immature, but investments are well spread by vintage and the portfolio is not overly concentrated, with the top five holdings representing 41% of portfolio value at end-2016.

12 months ending

Share price
(%)

NAV

(%)

LPX Europe
(%)

LPX Europe NAV (%)

SDAX
(%)

31/01/13

30.8

16.2

24.1

4.5

21.9

31/01/14

14.8

12.4

23.8

13.5

21.9

31/01/15

33.3

15.6

20.3

15.4

8.8

31/12/15*

14.6

15.1

14.0

7.5

18.9

31/12/16

4.8

8.7

10.3

7.5

4.6

Source: Thomson Datastream, Bloomberg. Note: *11-month period due to change in financial year end. Discrete total return performance in euros up to last reported NAV date.

Continuing strong portfolio activity in FY17

Less than seven months into FY17 (year ending 30 September 2017), DBAG has announced three new investments and two divestments, also completing two investments and one divestment agreed in H216. These transactions bring new investment to c €63m, continuing the strong pace of portfolio activity achieved over the previous two financial years. FY15 saw a significant step-up in new investment to €71.4m, which was well ahead of the €20.6m average for the prior 10 years, while FY16 new investment totalled €32.6m, with two of the agreed transactions (€27.2m) completing after the year end.

First two investments for DBAG Fund VII

The investment in a radiology group announced in March 2017 marked the first investment for the recently launched €1bn DBAG Fund VII. This was quickly followed by the announcement in April 2017 of two parallel management buyouts to form a convenience foods group. This represented another significant milestone, as management plans to utilise DBAG Fund VII’s top-up fund for this transaction to finance add-on acquisitions to expand the group. The initial investment by DBAG Fund VII for this transaction is €80m, with the top-up fund enabling equity capital investment to be increased up to €200m.

Valuation: 3.5% yield and sustainable dividend

DBAG shares are trading at a 34.1% premium to end-December 2016 NAV, which compares with a one-year average premium of 23.1% and a recent peak premium of 43.5%. In our view, the c €130m premium largely represents the market-implied value of DBAG’s fund services business, which is not reflected in reported NAV. DBAG’s 3.5% dividend yield is slightly above the peer group median.

Exhibit 1: Company at a glance

Investment objective and fund background

Recent developments

Deutsche Beteiligungs (DBAG) acquires subsidiaries of corporate groups and invests in mid-sized companies in Germany and neighbouring German-speaking countries via MBO transactions and growth capital financings. There is a focus on growth-driven profitable businesses valued at between €50m and €250m. DBAG’s core objective is to sustainably increase net asset value.

5 April 2017: MBO investment in European chilled convenience foods group, based on two parallel transactions to establish a European market leader.

29 March 2017: MBO investment in German radiology group, created from the merger of two radiology practices – the first investment for DBAG Fund VII.

24 February 2017: Sale of holding in FDG Group to CM-CIC Investissement.

9 February 2017: Q117 results – NAV TR +3.6% vs LPX Europe NAV TR +6.6%.

Forthcoming

Capital structure

Fund details

AGM

February 2018

FY16 net expense ratio*

1.5% (2.9% unadjusted)

Group

Deutsche Beteiligungs

Quarterly results

9 May 2017

Net cash

15.5%**

Manager

Team managed

Year end

30 September

Annual mgmt fee

N/A (self-managed)

Address

Boersenstrasse 1

60313 Frankfurt am Main, Germany

Dividend paid

February 2018

Performance fee

N/A (self-managed)

Launch date

December 1985

Trust life

Unlimited

Phone

+49 69 95787-01

Continuation vote

N/A

Loan facilities

€50m

Website

www.dbag.de

Dividend policy and history (financial years)

Share buyback policy and history (financial years)

Since FY16, DBAG’s policy has been to pay a stable or rising annual dividend. In previous years, a base annual dividend was paid from retained profits and supplemented by a surplus dividend based on realised gains.

DBAG uses share repurchases and capital increases to manage longer-term capital requirements. In September 2016, DBAG issued 1.4m new shares (10% of issued capital) at a 22.3% premium to NAV, raising €38.6m.

No. of portfolio companies by holding period (as at 31 December 2016)***

Portfolio exposure by sector (as at 31 December 2016)***

Shareholder base (as at 17 April 2017)

Concentration of portfolio value by size (as at 31 December 2016)***

Source: DBAG, Edison Investment Research, Thomson Datastream. Note: *Based on expenses net of fee income; adjusted for non-recurring items. **Including €46.8m of securities classified as long-term assets. ***Does not include co-investment funds.

FY17: A third year of strong portfolio activity

In FY17 to date, DBAG has completed the investments in Polytech Health and Frimo as well as the divestment of Broetje-Automation that were all announced in H216, with three further new investments and two divestments announced (see Exhibit 2). In total, these transactions bring FY17 new investment to c €63m, more than five months ahead of the financial year end.

Exhibit 2: DBAG’s portfolio investments and divestments in FY17 to date

Company

Headquarters

Core business

2016
revenue

Employees

First inv’t

Type of inv’t

Co-inv’t fund

Fund equity share

DBAG inv’t cost

DBAG equity share

FY17 investments

Polytech Health & Aesthetics

Dieburg, Germany

Silicone implants for plastic surgery in Europe

€31m

170

Oct-16

MBO

DBAG Fund VI

75.1%

€12.4m

17.6%

Frimo Group

Lotte, Germany

Plastic auto component tooling/ production plant worldwide

€212m

1,400

Nov-16

MBO

DBAG Fund VI

57.6%

€14.8m

13.5%

Dieter Braun

Bayreuth, Germany

Cable assembly/lighting for automotive industry worldwide

€77m

1,500

Jan-17

MBO

DBAG Fund VI

55.9%

€5.9m

13.1%

Radiology group

North Rhine-Westphalia, Germany

Diagnostic/therapeutic radiology services in Germany

€54m

87

Jun-17

MBO

DBAG Fund VII

45.0%

€15.0m

11.0%

Abbelen &
Oscar Mayer

Tönisworst, Germany & UK

Own-label ready meals/snacks for supermarkets in Europe

€433m

>2,650

Jun-17

MBO

DBAG Fund VII

64.0%

€15.0m

16.0%

FY17 divestments

Date sold

Broetje-Automation

Wiefelstede, Germany

Aircraft assembly automation machines/plant worldwide

Sold

Oct-16

Mar-12

MBO

DBAG Fund V

60.0%

€5.6m

15.0%

Grohmann Engineering

Prüm, Germany

Industrial automation plant development worldwide

Sold
Nov-16

Dec-96

Exp’n capital

N/A

0.0%

€2.1m

25.1%

FDG Group

Orly, France

Services for supermarkets in France/neighbouring countries

Sold
Mar-17

Jun-10

MBO

DBAG Fund V

63.8%

€2.2m

15.5%

Source: DBAG, Edison Investment Research

Having generated proceeds of €82m from the sale of its investment in Homag, which represented 36% of DBAG’s portfolio at end-July 2014, DBAG achieved a significant step-up in the pace of investment activity during FY15, as illustrated in Exhibit 3. Total new investment for the 11-month financial year to 30 September 2015 reached €71.4m, ahead of the target €50m pa run rate and the €20.6m average for the prior 10 years. Seven new companies were added to the portfolio in FY15, comprising five MBO and two expansion capital investments, all in DBAG’s core manufacturing and industrial services sectors, with two small divestments completed, resulting in an increase in the number of portfolio holdings from 19 to 24.

Exhibit 3: DBAG portfolio new investment value by financial year

Source: DBAG, Edison Investment Research. Note: *Included in €63.0m investments completed in 2017 ytd.

DBAG continued the strong pace of investment activity throughout FY16, agreeing investments in five new portfolio companies – three MBOs through DBAG Fund VI and two co-investments alongside DBAG ECF – as well as three divestments. New investment for the financial year totalled €32.6m, with two of these transactions (€27.2m) and a follow-on investment (c €1.9m), as well as one of the divestments, being completed after the year end.

Dieter Braun – final investment by DBAG Fund VI

In January 2017, DBAG invested €5.9m, alongside DBAG Fund VI, taking a 13.1% interest in Dieter Braun, in the management buyout of the business from financial investor Seafort Advisors. Braun is a specialist cable assembly and lighting supplier to the automotive industry, providing solutions involving a high degree of complexity and variable lead times. Founded in 1993 and headquartered in Bayreuth, Germany, Braun operates facilities in the Czech Republic, Ukraine, Mexico and China. Revenues have grown at 19% pa over the past seven years to €77m and it employs 1,500 staff.

Braun is benefiting from an increasing volume of electrical and electronic components in vehicles as well as the trend by OEMs and suppliers to outsource production processes. DBAG’s investment will support Braun’s capacity expansion and development of new production lines to meet growing demand and strengthen the company’s position in a fragmented market. In addition, there is potential to expand Braun’s product portfolio as well as broadening its geographical reach.

This acquisition represented the 11th investment by DBAG Fund VI, bringing its investment period to an end after less than four years – a year ahead of the fund’s scheduled investment period end in February 2018. With the fund 86% invested, remaining commitments will be available to support the growth of portfolio companies, including potential add-on acquisitions.

Radiology group – first investment by DBAG Fund VII

In March 2017, DBAG announced an investment in two radiology practices in the state of North Rhine-Westphalia, Germany, which will be merged to form a group. DBAG will invest €15m for an 11% stake in the group as part of the c 55% stake being taken by DBAG Fund VII through the management buyout, which represents its first investment. The interests held by 18 physicians who have managed and developed the two group practices are being acquired, with all reinvesting to hold a combined 44% stake in the group. The transaction is expected to complete by mid-2017, following regulatory approvals.

The radiology practices (www.radiologieherne.de, www.ranova.de) have provided outpatient and inpatient care for over 40 years, offering a complete range of radiological and nuclear medical examinations, therapy and interventions, acting as partners to private practices as well as hospitals. They operate at 15 locations, staffed by 87 physicians, and generated €54m total revenues in 2016.

DBAG’s investment will help finance ongoing development. Combining the practices and increasing the scale of the group is seen as an effective way to develop these capital-intensive medical services. Collectively, the practices can maintain high standards of quality, while providing their services cost-effectively due to their structure and size. Further organic development and acquisitions of other practices are planned as well as additional cooperative projects with hospitals.

Convenience food group – utilising DBAG Fund VII top-up fund

In April 2017, DBAG announced the management buyouts of family-owned businesses Abbelen and Oscar Mayer, aiming to establish a European market leader for chilled convenience products, primarily fresh ready meals and snacks. DBAG is investing €15m for a 16% stake as part of an €80m investment by DBAG Fund VII, which will hold an overall c 90% stake. The acquisitions are being made via a holding company, managed by Helmut Morent and Francois Legrain, who have extensive experience in the sector and jointly sourced the two transactions with DBAG. These two managers and group company senior executives will hold the remaining shares in the group.

Abbelen and Oscar Mayer will continue to be run autonomously, but will operate under the umbrella of the holding company, with the objective to expand the companies’ product ranges and broaden the group’s international distribution. The holding company will target add-on acquisitions, aiming to bring group revenues to more than €500m. DBAG Fund VII’s top-up fund will be used to finance add-on acquisitions, enabling equity capital investments of up to €200m for a single transaction.

Abbelen is the largest private-label manufacturer of meatballs and ready-made burgers in Germany, with revenues of €140m. From its meat processing factory in Tönisvorst (North Rhine-Westphalia), it supplies all of the large supermarket and discounter chains in Germany and bordering countries. Oscar Mayer is the leading producer of chilled prepared meals in the UK, which are sold under private labels of leading grocery retailers and discounters. The company operates four sites in England and Wales with a staff of c 2,650 and produces more than three million chilled prepared meals and snacks a week, generating revenues of £253m (c €293m) in its 2015/16 financial year.

Divestment of Grohmann Engineering

In November 2016, DBAG agreed the sale of Grohmann Engineering, a developer and manufacturer of plants for industrial automation, to strategic buyer Tesla Motors, after almost 30 years as a portfolio holding. DBAG management confirmed that sale proceeds of c €10m were above its most recent portfolio valuation, with the exit generating a mid-single digit positive value contribution.

DBAG’s investment in Grohmann Engineering dates from a growth financing by a predecessor company, which took a 25.1% stake in January 1987. DBAG assumed the entire interest in 1996, with no parallel investment by a DBAG managed fund. Over 20 years, Grohmann Engineering grew its revenues by over 6% pa to €123m in 2015, while employee numbers tripled to c 700. As well as DBAG’s 25.1% holding, Tesla acquired the 74.9% interest held by Klaus Grohmann, who founded the company in 1984.

Divestment of FDG Group

In March 2017, alongside DBAG Fund V and the company’s management, DBAG sold its holding in FDG Group, a supplier of non-food products to supermarkets primarily located in France, to the private equity arm of French banking group Crédit Mutuel-CIC. Financial terms have not been disclosed but DBAG management has confirmed that sales proceeds equate to more than twice the original investment and are in line with its most recent portfolio valuation.

DBAG acquired the FDG Group in June 2010 from its founding families, in collaboration with Quartus, its partner in the French market. Since 2010, with the objective to broaden its product range, FDG Group has grown organically and through the acquisition of two smaller companies, with net sales rising from €111m to c €123m in 2016, in the face of lacklustre economic growth in France. Efficiency gains were also achieved through greater integration of the highly decentralised group. The new owner will support FDG Group’s growth, with further add-on acquisitions planned.

Current portfolio positioning

After completing the three new investments and two divestments announced so far in FY17, DBAG’s portfolio will comprise 27 holdings, including two international buyout funds in the final stages of realisation (with a total of three remaining investments, representing c 3% of DBAG’s portfolio value). The recent strong pace of activity means that the portfolio is relatively immature, but investments are well spread by vintage, with five held for more than five years and 10 held for less than two years at end-December 2016. Although the portfolio holds a relatively small number of investments, it is not overly concentrated, with the top five holdings representing 41% of the portfolio by value at end-2016. At the same date, 76% of the portfolio by value was represented by companies from DBAG’s four core sectors of expertise: mechanical & plant engineering, automotive suppliers, industrial services providers and industrial components manufacturers (see Exhibit 1). While focused on these sectors, companies held in the portfolio operate across a wide range of industries with different dynamics and further diversification is provided by the 24% of the portfolio represented by companies operating in consumer-related industries.

Valuation

DBAG’s fund services business is not restated at fair value and therefore DBAG’s reported NAV does not reflect the prevailing market value of this business, while DBAG’s share price reflects the value of both DBAG’s investment and fund services businesses. We see the value of DBAG’s fund services business as the explanation for its shares trading at a premium to NAV in contrast with the majority of its listed private equity peers. In our view, the current c €130m premium to NAV largely represents the value that the market is attributing to DBAG’s fund services business. It is difficult to assess this valuation against the historical earnings of the fund services business, as these have varied between an €8.0m profit and a €3.0m loss over the last three years. DBAG management expects fee income to rise from €19.5m in FY16 to c €29.0m in FY18 due to the additional fees generated by DBAG Fund VII. We see this translating into fund services earnings between €4m and €7m in FY17 and FY18, giving a market-implied valuation multiple between 19x and 33x earnings.

As illustrated in Exhibit 4, DBAG shares have traded almost continuously at a premium to NAV since end-October 2014, when DBAG started reporting separately on its two business segments. The current 34.1% share price premium to NAV compares with a one-year average premium of 23.1% and a recent peak premium of 43.5%.

Exhibit 4: Share price premium/discount to NAV over three years (%)

Source: Thomson Datastream, Edison Investment Research

Peer group comparison

Exhibit 5 shows a comparison of DBAG with a selected peer group of listed private equity investment companies. DBAG is differentiated from the majority of its listed private equity peers by its focus on German mid-market companies and its fund services business. Relative to the peer group average, DBAG’s NAV total return in sterling terms to 31 December 2016 is lower over one and three years, ahead over five years and substantially ahead over 10 years. Although weaker over one year, DBAG’s share price total return has outperformed its NAV total return over three, five and 10 years to end-December 2016, which reflects the shares moving to trade at a premium to NAV since DBAG first reported separately on its fund services business at end-FY14. Similar to 3i, which also manages third-party funds, DBAG’s shares are trading at a substantial premium to NAV in contrast to the majority of the peer group, some of which are trading at a significant discount to NAV. DBAG’s 3.5% dividend yield is slightly above the peer group median but below the average (largely due to Electra Private Equity’s yield being inflated by its March 2017 special dividend).

Exhibit 5: Listed private equity investment companies peer group, as at 20 April 2017*

% unless stated

Country

Mkt cap £m

NAV TR 1 year

NAV TR 3 years

NAV TR 5 years

NAV TR 10 years

Price TR 1 year

Price TR 3 years

Price TR 5 years

Price TR 10 years

Discount (ex-par)

Dividend yield (%)

Deutsche Beteiligungs

Europe

429.5

27.0

51.4

95.6

219.4

22.4

67.4

148.5

270.1

33.2

3.5

3i

Global

7,523.1

42.0

100.2

139.7

52.8

52.5

107.9

377.4

27.7

38.4

2.8

Altamir

Europe

438.4

39.8

63.4

109.2

129.6

40.3

46.1

169.5

132.0

(33.8)

4.6

GIMV

Global

1,136.0

31.5

55.9

76.4

118.5

31.5

55.9

76.4

118.5

6.1

3.5

Electra Private Equity

UK

983.1

40.2

99.0

143.7

265.4

34.8

115.3

262.6

260.0

(8.7)

6.0

HgCapital Trust

UK

569.2

19.5

53.0

69.5

178.7

43.1

70.5

82.9

178.3

(7.7)

3.0

ICG Enterprise Trust

UK

490.4

19.5

28.8

57.5

108.4

19.8

24.0

124.4

108.6

(17.7)

2.9

Oakley Capital Investments

Europe

313.4

17.9

17.9

37.9

16.9

(10.6)

27.0

(32.2)

2.9

Standard Life Private Equity

Europe

488.9

29.9

52.5

71.5

108.1

43.0

59.0

158.8

67.6

(9.0)

3.8

Average

1,374.7

29.7

58.0

89.0

147.6

33.8

59.5

158.6

145.3

(3.5)

3.7

Rank in peer group

8

6

7

4

2

7

4

5

1

2

4

Source: Morningstar, Edison Investment Research. Note: *Performance data to end-December 2016. TR=total return. All returns expressed in sterling terms.

Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world-renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisers and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting. Edison is authorised and regulated by the Financial Conduct Authority (www.fsa.gov.uk/register/firmBasicDetails.do?sid=181584). Edison Investment Research (NZ) Limited (Edison NZ) is the New Zealand subsidiary of Edison. Edison NZ is registered on the New Zealand Financial Service Providers Register (FSP number 247505) and is registered to provide wholesale and/or generic financial adviser services only. Edison Investment Research Inc (Edison US) is the US subsidiary of Edison and is regulated by the Securities and Exchange Commission. Edison Investment Research Limited (Edison Aus) [46085869] is the Australian subsidiary of Edison and is not regulated by the Australian Securities and Investment Commission. Edison Germany is a branch entity of Edison Investment Research Limited [4794244]. www.edisongroup.com

DISCLAIMER
Copyright 2017 Edison Investment Research Limited. All rights reserved. This report has been commissioned by Deutsche Beteiligungs and prepared and issued by Edison for publication globally. All information used in the publication of this report has been compiled from publicly available sources that are believed to be reliable; however we do not guarantee the accuracy or completeness of this report. Opinions contained in this report represent those of the research department of Edison at the time of publication. The securities described in the Investment Research may not be eligible for sale in all jurisdictions or to certain categories of investors. This research is issued in Australia by Edison Aus and any access to it, is intended only for "wholesale clients" within the meaning of the Australian Corporations Act. The Investment Research is distributed in the United States by Edison US to major US institutional investors only. Edison US is registered as an investment adviser with the Securities and Exchange Commission. Edison US relies upon the "publishers' exclusion" from the definition of investment adviser under Section 202(a)(11) of the Investment Advisers Act of 1940 and corresponding state securities laws. As such, Edison does not offer or provide personalised advice. We publish information about companies in which we believe our readers may be interested and this information reflects our sincere opinions. The information that we provide or that is derived from our website is not intended to be, and should not be construed in any manner whatsoever as, personalised advice. Also, our website and the information provided by us should not be construed by any subscriber or prospective subscriber as Edison’s solicitation to effect, or attempt to effect, any transaction in a security. The research in this document is intended for New Zealand resident professional financial advisers or brokers (for use in their roles as financial advisers or brokers) and habitual investors who are “wholesale clients” for the purpose of the Financial Advisers Act 2008 (FAA) (as described in sections 5(c) (1)(a), (b) and (c) of the FAA). This is not a solicitation or inducement to buy, sell, subscribe, or underwrite any securities mentioned or in the topic of this document. This document is provided for information purposes only and should not be construed as an offer or solicitation for investment in any securities mentioned or in the topic of this document. A marketing communication under FCA rules, this document has not been prepared in accordance with the legal requirements designed to promote the independence of investment research and is not subject to any prohibition on dealing ahead of the dissemination of investment research. Edison has a restrictive policy relating to personal dealing. Edison Group does not conduct any investment business and, accordingly, does not itself hold any positions in the securities mentioned in this report. However, the respective directors, officers, employees and contractors of Edison may have a position in any or related securities mentioned in this report. Edison or its affiliates may perform services or solicit business from any of the companies mentioned in this report. The value of securities mentioned in this report can fall as well as rise and are subject to large and sudden swings. In addition it may be difficult or not possible to buy, sell or obtain accurate information about the value of securities mentioned in this report. Past performance is not necessarily a guide to future performance. Forward-looking information or statements in this report contain information that is based on assumptions, forecasts of future results, estimates of amounts not yet determinable, and therefore involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of their subject matter to be materially different from current expectations. For the purpose of the FAA, the content of this report is of a general nature, is intended as a source of general information only and is not intended to constitute a recommendation or opinion in relation to acquiring or disposing (including refraining from acquiring or disposing) of securities. The distribution of this document is not a “personalised service” and, to the extent that it contains any financial advice, is intended only as a “class service” provided by Edison within the meaning of the FAA (ie without taking into account the particular financial situation or goals of any person). As such, it should not be relied upon in making an investment decision. To the maximum extent permitted by law, Edison, its affiliates and contractors, and their respective directors, officers and employees will not be liable for any loss or damage arising as a result of reliance being placed on any of the information contained in this report and do not guarantee the returns on investments in the products discussed in this publication. FTSE International Limited (“FTSE”) © FTSE 2017. “FTSE®” is a trade mark of the London Stock Exchange Group companies and is used by FTSE International Limited under license. All rights in the FTSE indices and/or FTSE ratings vest in FTSE and/or its licensors. Neither FTSE nor its licensors accept any liability for any errors or omissions in the FTSE indices and/or FTSE ratings or underlying data. No further distribution of FTSE Data is permitted without FTSE’s express written consent.

Frankfurt +49 (0)69 78 8076 960

Schumannstrasse 34b

60325 Frankfurt

Germany

London +44 (0)20 3077 5700

280 High Holborn

London, WC1V 7EE

United Kingdom

New York +1 646 653 7026

245 Park Avenue, 39th Floor

10167, New York

US

Sydney +61 (0)2 8249 8342

Level 12, Office 1205

95 Pitt Street, Sydney

NSW 2000, Australia

Frankfurt +49 (0)69 78 8076 960

Schumannstrasse 34b

60325 Frankfurt

Germany

London +44 (0)20 3077 5700

280 High Holborn

London, WC1V 7EE

United Kingdom

New York +1 646 653 7026

245 Park Avenue, 39th Floor

10167, New York

US

Sydney +61 (0)2 8249 8342

Level 12, Office 1205

95 Pitt Street, Sydney

NSW 2000, Australia

Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world-renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisers and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting. Edison is authorised and regulated by the Financial Conduct Authority (www.fsa.gov.uk/register/firmBasicDetails.do?sid=181584). Edison Investment Research (NZ) Limited (Edison NZ) is the New Zealand subsidiary of Edison. Edison NZ is registered on the New Zealand Financial Service Providers Register (FSP number 247505) and is registered to provide wholesale and/or generic financial adviser services only. Edison Investment Research Inc (Edison US) is the US subsidiary of Edison and is regulated by the Securities and Exchange Commission. Edison Investment Research Limited (Edison Aus) [46085869] is the Australian subsidiary of Edison and is not regulated by the Australian Securities and Investment Commission. Edison Germany is a branch entity of Edison Investment Research Limited [4794244]. www.edisongroup.com

DISCLAIMER
Copyright 2017 Edison Investment Research Limited. All rights reserved. This report has been commissioned by Deutsche Beteiligungs and prepared and issued by Edison for publication globally. All information used in the publication of this report has been compiled from publicly available sources that are believed to be reliable; however we do not guarantee the accuracy or completeness of this report. Opinions contained in this report represent those of the research department of Edison at the time of publication. The securities described in the Investment Research may not be eligible for sale in all jurisdictions or to certain categories of investors. This research is issued in Australia by Edison Aus and any access to it, is intended only for "wholesale clients" within the meaning of the Australian Corporations Act. The Investment Research is distributed in the United States by Edison US to major US institutional investors only. Edison US is registered as an investment adviser with the Securities and Exchange Commission. Edison US relies upon the "publishers' exclusion" from the definition of investment adviser under Section 202(a)(11) of the Investment Advisers Act of 1940 and corresponding state securities laws. As such, Edison does not offer or provide personalised advice. We publish information about companies in which we believe our readers may be interested and this information reflects our sincere opinions. The information that we provide or that is derived from our website is not intended to be, and should not be construed in any manner whatsoever as, personalised advice. Also, our website and the information provided by us should not be construed by any subscriber or prospective subscriber as Edison’s solicitation to effect, or attempt to effect, any transaction in a security. The research in this document is intended for New Zealand resident professional financial advisers or brokers (for use in their roles as financial advisers or brokers) and habitual investors who are “wholesale clients” for the purpose of the Financial Advisers Act 2008 (FAA) (as described in sections 5(c) (1)(a), (b) and (c) of the FAA). This is not a solicitation or inducement to buy, sell, subscribe, or underwrite any securities mentioned or in the topic of this document. This document is provided for information purposes only and should not be construed as an offer or solicitation for investment in any securities mentioned or in the topic of this document. A marketing communication under FCA rules, this document has not been prepared in accordance with the legal requirements designed to promote the independence of investment research and is not subject to any prohibition on dealing ahead of the dissemination of investment research. Edison has a restrictive policy relating to personal dealing. Edison Group does not conduct any investment business and, accordingly, does not itself hold any positions in the securities mentioned in this report. However, the respective directors, officers, employees and contractors of Edison may have a position in any or related securities mentioned in this report. Edison or its affiliates may perform services or solicit business from any of the companies mentioned in this report. The value of securities mentioned in this report can fall as well as rise and are subject to large and sudden swings. In addition it may be difficult or not possible to buy, sell or obtain accurate information about the value of securities mentioned in this report. Past performance is not necessarily a guide to future performance. Forward-looking information or statements in this report contain information that is based on assumptions, forecasts of future results, estimates of amounts not yet determinable, and therefore involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of their subject matter to be materially different from current expectations. For the purpose of the FAA, the content of this report is of a general nature, is intended as a source of general information only and is not intended to constitute a recommendation or opinion in relation to acquiring or disposing (including refraining from acquiring or disposing) of securities. The distribution of this document is not a “personalised service” and, to the extent that it contains any financial advice, is intended only as a “class service” provided by Edison within the meaning of the FAA (ie without taking into account the particular financial situation or goals of any person). As such, it should not be relied upon in making an investment decision. To the maximum extent permitted by law, Edison, its affiliates and contractors, and their respective directors, officers and employees will not be liable for any loss or damage arising as a result of reliance being placed on any of the information contained in this report and do not guarantee the returns on investments in the products discussed in this publication. FTSE International Limited (“FTSE”) © FTSE 2017. “FTSE®” is a trade mark of the London Stock Exchange Group companies and is used by FTSE International Limited under license. All rights in the FTSE indices and/or FTSE ratings vest in FTSE and/or its licensors. Neither FTSE nor its licensors accept any liability for any errors or omissions in the FTSE indices and/or FTSE ratings or underlying data. No further distribution of FTSE Data is permitted without FTSE’s express written consent.

Frankfurt +49 (0)69 78 8076 960

Schumannstrasse 34b

60325 Frankfurt

Germany

London +44 (0)20 3077 5700

280 High Holborn

London, WC1V 7EE

United Kingdom

New York +1 646 653 7026

245 Park Avenue, 39th Floor

10167, New York

US

Sydney +61 (0)2 8249 8342

Level 12, Office 1205

95 Pitt Street, Sydney

NSW 2000, Australia

Frankfurt +49 (0)69 78 8076 960

Schumannstrasse 34b

60325 Frankfurt

Germany

London +44 (0)20 3077 5700

280 High Holborn

London, WC1V 7EE

United Kingdom

New York +1 646 653 7026

245 Park Avenue, 39th Floor

10167, New York

US

Sydney +61 (0)2 8249 8342

Level 12, Office 1205

95 Pitt Street, Sydney

NSW 2000, Australia

Share this with friends and colleagues